Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)

Methylene Blue (MB) is combined with radiopharmaceutical for intraoperative sentinel lymph node (SLN) mapping, but its role during SLN extirpation has not been investigated yet in veterinary medicine. The aim of this study was to assess whether MB increased surgical detection of SLN beyond the use o...

Full description

Bibliographic Details
Main Authors: Elisa Maria Gariboldi, Alessandra Ubiali, Lavinia Elena Chiti, Roberta Ferrari, Donatella De Zani, Davide Danilo Zani, Valeria Grieco, Chiara Giudice, Camilla Recordati, Damiano Stefanello, Luigi Auletta
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/13/11/1854
_version_ 1827739831326736384
author Elisa Maria Gariboldi
Alessandra Ubiali
Lavinia Elena Chiti
Roberta Ferrari
Donatella De Zani
Davide Danilo Zani
Valeria Grieco
Chiara Giudice
Camilla Recordati
Damiano Stefanello
Luigi Auletta
author_facet Elisa Maria Gariboldi
Alessandra Ubiali
Lavinia Elena Chiti
Roberta Ferrari
Donatella De Zani
Davide Danilo Zani
Valeria Grieco
Chiara Giudice
Camilla Recordati
Damiano Stefanello
Luigi Auletta
author_sort Elisa Maria Gariboldi
collection DOAJ
description Methylene Blue (MB) is combined with radiopharmaceutical for intraoperative sentinel lymph node (SLN) mapping, but its role during SLN extirpation has not been investigated yet in veterinary medicine. The aim of this study was to assess whether MB increased surgical detection of SLN beyond the use of intraoperative gamma-probe (IGP) alone in clinically node-negative dogs with mast cell tumors (MCTs) following the detection of sentinel lymphocentrums (SLCs) via preoperative planar lymphoscintigraphy. Dogs enrolled underwent MCT excision and SLC exploration guided by both MB and IGP. Data recorded for each SLN were staining (blue/non-blue), radioactivity (hot/non-hot), and histopathological status (HN0-1 vs. HN2-3). A total of 103 dogs bearing 80 cutaneous, 35 subcutaneous, and 1 mucocutaneous MCTs were included; 140 SLCs were explored, for a total of 196 SLNs removed. Associating MB with IGP raised the SLNs detection rate from 90% to 95%. A total of 44% of SLNs were metastatic: 86% were blue/hot, 7% were only blue, 5% were only hot, and 2% were non-blue/non-hot. All HN3 SLNs were hot. Combining MB with IGP can increase the rate of SLN detection in dogs with MCTs; nonetheless, all lymph nodes identified during dissection should be removed, as they might be unstained but metastatic.
first_indexed 2024-03-11T03:12:37Z
format Article
id doaj.art-936d2a6876024fdf8363834e7f11c2bd
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-11T03:12:37Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-936d2a6876024fdf8363834e7f11c2bd2023-11-18T07:30:35ZengMDPI AGAnimals2076-26152023-06-011311185410.3390/ani13111854Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)Elisa Maria Gariboldi0Alessandra Ubiali1Lavinia Elena Chiti2Roberta Ferrari3Donatella De Zani4Davide Danilo Zani5Valeria Grieco6Chiara Giudice7Camilla Recordati8Damiano Stefanello9Luigi Auletta10Department of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyDepartment of Veterinary Medicine and Animal Sciences, Università degli Studi di Milano, 26900 Lodi, ItalyMethylene Blue (MB) is combined with radiopharmaceutical for intraoperative sentinel lymph node (SLN) mapping, but its role during SLN extirpation has not been investigated yet in veterinary medicine. The aim of this study was to assess whether MB increased surgical detection of SLN beyond the use of intraoperative gamma-probe (IGP) alone in clinically node-negative dogs with mast cell tumors (MCTs) following the detection of sentinel lymphocentrums (SLCs) via preoperative planar lymphoscintigraphy. Dogs enrolled underwent MCT excision and SLC exploration guided by both MB and IGP. Data recorded for each SLN were staining (blue/non-blue), radioactivity (hot/non-hot), and histopathological status (HN0-1 vs. HN2-3). A total of 103 dogs bearing 80 cutaneous, 35 subcutaneous, and 1 mucocutaneous MCTs were included; 140 SLCs were explored, for a total of 196 SLNs removed. Associating MB with IGP raised the SLNs detection rate from 90% to 95%. A total of 44% of SLNs were metastatic: 86% were blue/hot, 7% were only blue, 5% were only hot, and 2% were non-blue/non-hot. All HN3 SLNs were hot. Combining MB with IGP can increase the rate of SLN detection in dogs with MCTs; nonetheless, all lymph nodes identified during dissection should be removed, as they might be unstained but metastatic.https://www.mdpi.com/2076-2615/13/11/1854veterinary oncologysentinel lymphocentrumsentinel lymph nodemast cell tumorcanineintraoperative mapping
spellingShingle Elisa Maria Gariboldi
Alessandra Ubiali
Lavinia Elena Chiti
Roberta Ferrari
Donatella De Zani
Davide Danilo Zani
Valeria Grieco
Chiara Giudice
Camilla Recordati
Damiano Stefanello
Luigi Auletta
Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
Animals
veterinary oncology
sentinel lymphocentrum
sentinel lymph node
mast cell tumor
canine
intraoperative mapping
title Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
title_full Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
title_fullStr Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
title_full_unstemmed Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
title_short Evaluation of Surgical Aid of Methylene Blue in Addition to Intraoperative Gamma Probe for Sentinel Lymph Node Extirpation in 116 Canine Mast Cell Tumors (2017–2022)
title_sort evaluation of surgical aid of methylene blue in addition to intraoperative gamma probe for sentinel lymph node extirpation in 116 canine mast cell tumors 2017 2022
topic veterinary oncology
sentinel lymphocentrum
sentinel lymph node
mast cell tumor
canine
intraoperative mapping
url https://www.mdpi.com/2076-2615/13/11/1854
work_keys_str_mv AT elisamariagariboldi evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT alessandraubiali evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT laviniaelenachiti evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT robertaferrari evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT donatelladezani evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT davidedanilozani evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT valeriagrieco evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT chiaragiudice evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT camillarecordati evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT damianostefanello evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022
AT luigiauletta evaluationofsurgicalaidofmethyleneblueinadditiontointraoperativegammaprobeforsentinellymphnodeextirpationin116caninemastcelltumors20172022